Inventor
SALITURO FRANCESCO G
US144 patents
⚠️ This page may combine multiple inventors who share the name “SALITURO FRANCESCO G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SAGE THERAPEUTICS INC
33 patentsUS10246482B2Apr 2, 2019
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC38 citations98
US9725481B2Aug 8, 2017
19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
SAGE THERAPEUTICS INC46 citations98
US9512165B2Dec 6, 2016
19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
SAGE THERAPEUTICS INC71 citations98
US9365611B2Jun 14, 2016
19-NOR neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC49 citations98
US11241446B2Feb 8, 2022
19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
SAGE THERAPEUTICS INC12 citations94
US11149054B2Oct 19, 2021
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC14 citations94
US11111266B2Sep 7, 2021
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC15 citations94
US11104701B2Aug 31, 2021
Neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC16 citations94
US10723758B2Jul 28, 2020
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC20 citations94
US10696712B2Jun 30, 2020
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC21 citations94
US10342810B2Jul 9, 2019
19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
SAGE THERAPEUTICS INC17 citations94
US10329320B2Jun 25, 2019
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC18 citations94
US10259840B2Apr 16, 2019
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC30 citations94
US10227375B2Mar 12, 2019
Neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC33 citations94
US10201550B2Feb 12, 2019
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC23 citations94
US10172871B2Jan 8, 2019
19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
SAGE THERAPEUTICS INC20 citations94
US11926646B2Mar 12, 2024
C7 substituted oxysterols and methods of use thereof
SAGE THERAPEUTICS INC5 citations86
US11905309B2Feb 20, 2024
Neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC5 citations86
US11884697B2Jan 30, 2024
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC6 citations86
US11878995B2Jan 23, 2024
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC5 citations86
US11780875B2Oct 10, 2023
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC4 citations86
US11732000B2Aug 22, 2023
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC6 citations86
US11613556B2Mar 28, 2023
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC6 citations86
US11542297B2Jan 3, 2023
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC9 citations86
US11530237B2Dec 20, 2022
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC9 citations86
US11396525B2Jul 26, 2022
C17, C20, and C21 substituted neuroactive steroids and their methods of use
SAGE THERAPEUTICS INC8 citations86
US11344563B2May 31, 2022
19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
SAGE THERAPEUTICS INC8 citations86
US11261211B2Mar 1, 2022
19-NOR neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC8 citations86
US11149057B2Oct 19, 2021
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC9 citations86
US11124538B2Sep 21, 2021
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC9 citations86
US10870677B2Dec 22, 2020
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC13 citations86
US10774108B2Sep 15, 2020
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC12 citations86
US11498940B2Nov 15, 2022
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC8 citations85
VERTEX PHARMA
7 patentsUS8829007B2Sep 9, 2014
Inhibitors of influenza viruses replication
VERTEX PHARMA28 citations95
US9808459B2Nov 7, 2017
Inhibitors of influenza viruses replication
VERTEX PHARMA11 citations92
US9518056B2Dec 13, 2016
Inhibitors of influenza viruses replication
VERTEX PHARMA16 citations92
US9345708B2May 24, 2016
Inhibitors of influenza viruses replication
VERTEX PHARMA21 citations92
US7598245B2Oct 6, 2009
Aminotriazole compounds useful as inhibitors of protein kinases
VERTEX PHARMA25 citations92
US6693108B2Feb 17, 2004
Inhibitors of c-JUN N terminal kinases (JNK) and other protein kinases
VERTEX PHARMA20 citations92
US7279469B2Oct 9, 2007
Diaminotriazoles useful as inhibitors of protein kinases
VERTEX PHARMA36 citations90
SALITURO FRANCESCO G
4 patentsUS8742119B2Jun 3, 2014
Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use
SALITURO FRANCESCO G39 citations98
US8785450B2Jul 22, 2014
Therapeutic compounds and compositions
SALITURO FRANCESCO G45 citations97
US9328077B2May 3, 2016
Bicyclic PKM2 activators
SALITURO FRANCESCO G21 citations92
US8889667B2Nov 18, 2014
Therapeutic compounds and compositions
SALITURO FRANCESCO G28 citations91
AGIOS PHARMACEUTICALS INC
3 patentsUS9512107B2Dec 6, 2016
Therapeutically active compositions and their methods of use
AGIOS PHARMACEUTICALS INC25 citations94
US9732062B2Aug 15, 2017
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC18 citations92
US9656999B2May 23, 2017
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC16 citations92
MERRELL DOW PHARMA
2 patentsMERRELL PHARMA INC
1 patentShowing the top 50 of 144 patents by PatentIndex Score.